Cargando…
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Fumarates improve multiple sclerosis (MS) and psoriasis, two diseases in which both IL-12 and IL-23 promote pathogenic T helper (Th) cell differentiation. However, both diseases show opposing responses to most established therapies. First, we show in humans that fumarate treatment induces IL-4–produ...
Autores principales: | Ghoreschi, Kamran, Brück, Jürgen, Kellerer, Christina, Deng, Caishu, Peng, Haiyan, Rothfuss, Oliver, Hussain, Rehana Z., Gocke, Anne R., Respa, Annedore, Glocova, Ivana, Valtcheva, Nadejda, Alexander, Eva, Feil, Susanne, Feil, Robert, Schulze-Osthoff, Klaus, Rupec, Rudolf A., Lovett-Racke, Amy E., Dringen, Ralf, Racke, Michael K., Röcken, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201195/ https://www.ncbi.nlm.nih.gov/pubmed/21987655 http://dx.doi.org/10.1084/jem.20100977 |
Ejemplares similares
-
PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis
por: Yang, Yuhong, et al.
Publicado: (2008) -
Advances in treating psoriasis
por: Belge, Katharina, et al.
Publicado: (2014) -
Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs
por: Yang, Yuhong, et al.
Publicado: (2010) -
Recent advances in understanding psoriasis
por: Eberle, Franziska C., et al.
Publicado: (2016) -
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate
por: Nicholas, Jacqueline Ann, et al.
Publicado: (2014)